Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» pancreatic cancer
pancreatic cancer
FDA Approves AstraZeneca and Merck's Lynparza for Pancreatic Cancer
BioSpace
Mon, 12/30/19 - 05:39 pm
AstraZeneca
Merck
Lynparza
pancreatic cancer
FDA
Arcus and Roche Partner on Colorectal and Pancreatic Cancer Trials
BioSpace
Thu, 12/19/19 - 12:45 pm
Roche
Genentech
Arcus Biosciences
clinical trials
colorectal cancer
pancreatic cancer
AB928
AZ, Merck's Lynparza narrowly snags FDA panel backing in pancreatic cancer
Fierce Pharma
Tue, 12/17/19 - 09:19 pm
AstraZeneca
Merck
Lynparza
pancreatic cancer
FDA
advisory panels
Is AZ, Merck's Lynparza approvable in pancreatic cancer sans survival benefit? FDA's about to decide
Fierce Pharma
Mon, 12/16/19 - 10:42 am
AstraZeneca
Merck
Lynparza
FDA
BRCA-mutated pancreatic cancer
pancreatic cancer
Halozyme to Restructure After Pancreatic Cancer Drug Fails in Phase 3; 55% of Workforce to be Cut
Xconomy
Mon, 11/4/19 - 10:42 am
Halozyme Therapeutics
pancreatic cancer
clinical trials
restructuring
layoffs
PEGPH20
GlaxoSmithKline's RIPK1 inhibitor dead on arrival
Fierce Biotech
Wed, 10/30/19 - 10:06 am
GSK
GSK095
pancreatic cancer
Lilly cancer drug pipeline hit by trial setback
Biopharma Dive
Wed, 10/16/19 - 12:21 pm
Eli Lilly
pegilodecakin
immunotherapy
pancreatic cancer
ARMO BioSciences
Growing tumors in a dish, scientists try to personalize pancreatic cancer treatment
Stat
Sun, 10/6/19 - 12:29 pm
pancreatic cancer
AstraZeneca drug heads to phase 2 in pancreatic cancer after small trial extends survival
Fierce Biotech
Thu, 08/15/19 - 12:27 pm
AstraZeneca
pancreatic cancer
DNA
University of Michigan
AZD1775
Stopping the spread of pancreatic cancer
Fierce Biotech
Mon, 08/12/19 - 10:38 am
pancreatic cancer
immuno-oncology
Did cancer clinical trials stay on track at ASCO 2019?
Pharmaforum
Fri, 07/19/19 - 01:00 pm
ASCO
clinical trials
cancer
ASCO 2019
bladder cancer
breast cancer
prostate cancer
pancreatic cancer
Ipsen, Servier announce initial phase 1/2 data of liposomal irinotecan in metastatic pancreatic cancer
Pharmaceutical Business Review
Mon, 07/8/19 - 10:25 am
Ipsen
Servier
liposomal irinotecan
pancreatic cancer
Pancreatic Cancer Update: Abandoned Trial, Exciting Research, New Appointments
BioSpace
Tue, 07/2/19 - 11:52 pm
pancreatic cancer
Boston Biomedical
Cold Spring Harbor Laboratory
PanCan
Another effort on pancreatic cancer flops, as Boston Biomedical cans phase 3 combo test
Fierce Biotech
Tue, 07/2/19 - 10:30 am
Boston Biomedical
clinical trials
pancreatic cancer
napabucasin
How a long-known biomarker backs BioNTech's antibody for pancreatic cancer
Fierce Biotech
Thu, 06/20/19 - 07:56 pm
BioNTech
pancreatic cancer
CA19-9
biomarkers
Early cancer drug data give Amgen hope it's 'cracked KRAS code'
Biopharma Dive
Mon, 06/3/19 - 11:30 am
ASCO 2019
KRAS
lung cancer
colorectal cancer
pancreatic cancer
Amgen
AMG 510
ASCO 2019 day three
Pharmaforum
Sun, 06/2/19 - 01:09 pm
ASCO 2019
Merck
AstraZeneca
pancreatic cancer
Novartis
alpelisib
Roche
entrectinib
Breakthrough in Pancreatic Cancer Research Could Lead to New Treatments
BioSpace
Fri, 05/3/19 - 10:34 pm
pancreatic cancer
genes
R&D
Early pancreatic cancer data give Clovis a new path in PARP market
Biopharma Dive
Tue, 04/2/19 - 04:22 pm
pancreatic cancer
Clovis Oncology
AstraZeneca
PARP inhibitors
AACR
Rubraca
Lynparza
Despite research boom, few immunotherapy studies targeting pancreatic cancer
Biopharma Dive
Mon, 04/1/19 - 12:18 pm
pancreatic cancer
cancer immunotherapy
AACR
Bristol-Myers Squibb
Merck
Apexigen
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
next ›
last »